Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106497996B reveals a high-ee enzymatic route for chiral alcohols. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN103695443A reveals ChKRED03 for synthesizing chiral alcohols. Offers cost reduction in chiral alcohol manufacturing and reliable supply chain solutions.
Patent CN115976129A reveals a novel enzymatic route for ergothioneine. Discover cost reduction in nutritional ingredients manufacturing and supply chain reliability.
Patent CN109554406A enables efficient keto acid production. Reduces coenzyme cost and improves supply chain reliability for pharma intermediates.
Patent CN104774889B details a novel fructosyltransferase method for sucrose-6-acetate, offering high yield and purity for reliable supply chain integration.
Novel carbonyl reductase mutant enables high-purity chiral intermediate synthesis with reduced solvent waste and cost for pharmaceutical supply chains.
Patent CN119823959B reveals novel imine reductase mutants for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112852894A reveals SpAmDH mutant for high-purity chiral amino alcohol. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN105441401A reveals enzymatic route for HCV intermediates. Reduces heavy metal use and simplifies scale-up for reliable supply.
Patent CN108300744B reveals enzymatic synthesis for high-purity D-heterocyclic amino acids. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Patent CN1942476A details enzymatic acylation of rapamycin. Offers high yield, mild conditions, and eliminates heavy metal catalysts for pharmaceutical intermediates.
Patent CN103937759B reveals a novel biocatalytic route for statin intermediates. Discover cost reduction and supply chain reliability advantages for pharmaceutical manufacturing.
Patent CN116926139A reveals a novel enzymatic route for N-acetyl-D-amino acid production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101423861B reveals green biocatalytic route for L-phenylalanine. Eliminates metal catalysts ensuring supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108441433A reveals biocatalytic route for high-purity chiral alcohol. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101906447B reveals a biocatalytic route for 3,6-dichloropyrimidine-2-carboxylic acid. This method offers significant cost reduction in agrochemical manufacturing and enhanced supply chain reliability.
Novel enzymatic route for R-3-aminopiperidine dihydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Patent CN115772508B reveals high-activity DAAO mutants for efficient L-glufosinate intermediate production, offering significant cost and supply chain advantages.